Revivaa Biotech Private Limited
About Revivaa Biotech Private Limited
Data last updated:
Revivaa Biotech Private Limited was a private limited company based in New Delhi, Delhi, India, operated as a subsidiary of Rajasthan Antibiotics Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 April 2010.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U52100DL2010PTC201633. Its GSTIN is 08AAFCR1102C1Z3 (Rajasthan).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Aashish Pruthii and Rakesh Kumar Girdhar.
Its last annual general meeting (AGM) was held on 29 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at M – 134 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2020, the company reported a revenue of ₹12 Lakh, a growth of 82% compared to the previous year. For the same year it recorded a net profit of ₹8.7 Lakh (net margin 72.5%) and EBITDA of ₹11.76 Lakh (EBITDA margin 98%).
Company details
Contact details
Revivaa Biotech Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressM – 134 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Revivaa Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Revivaa Biotech Private Limited
FY 2020 filings availableRevivaa Biotech Private Limited reported revenue of ₹12 Lakh (up 82% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 82% in the latest year. EBITDA rose 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹12 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 98% | ||||
| Net Profit Margin | 72.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Revivaa Biotech Private Limited, buy the company report.
Board of directors of Revivaa Biotech Private Limited
Revivaa Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aashish Pruthii Also directs: Rajasthan Antibiotics Ltd, Ral Nutralife Private Limited | Director | 16 Apr 2010 | 16 Years 6 Months | As last reported |
| Rakesh Kumar Girdhar Also directs: Rajasthan Antibiotics Ltd, Ral Nutralife Private Limited | Director | 16 Apr 2010 | 16 Years 6 Months | As last reported |
Peer comparison
Revivaa Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orbal Healthcare Private Limited | ₹12.11 Lakh (FY 2025) | 348.0% | Ahmedabad, Gujarat, India | |||
| Utopia Medihealth Private Limited | ₹12.09 Lakh (FY 2024) | -46.0% | Lucknow, Uttar Pradesh, India | |||
| Ravaxo Pharmaceutical Private Limited | ₹12.04 Lakh (FY 2025) | 51.0% | Surendranagar, Gujarat, India | |||
| Zoomex Therapeutics Private Limited | ₹12.03 Lakh (FY 2022) | -26.0% | Kozhikode, Kerala, India | |||
| Glopec International (India) Private Limited | ₹12.02 Lakh (FY 2025) | 165979.0% | Secunderabad, Telangana, India | |||
| Revivaa Biotech Private Limitedthis company | ₹12 Lakh (FY 2020) | ₹8.7 Lakh | 72.5% | 82.0% | New Delhi, Delhi, India | |
| Healonn Globalmed Private Limited | ₹11.99 Lakh (FY 2025) | -23.0% | New Delhi, Delhi, India | |||
| Poddar Healthcare Private Limited | ₹11.99 Lakh (FY 2024) | 98.0% | Hardwar, Uttarakhand, India | |||
| Zemlin Healthcare Private Limited | ₹11.97 Lakh (FY 2025) | Delhi, India | ||||
| Copan India Private Limited | ₹11.96 Lakh (FY 2025) | Bhiwandi, Maharashtra, India | ||||
| Zahracure Exim Private Limited | ₹11.94 Lakh (FY 2025) | -94.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Revivaa Biotech Private Limited, buy the company report.
Auditor
Revivaa Biotech Private Limited is audited by S K D & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K D & ASSOCIATES | FY 2019 | 023842N |
Shareholding
The shareholding of Revivaa Biotech Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Revivaa Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Revivaa Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revivaa Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Revivaa Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAFCR1102C1Z3 | Rajasthan | Active | 23 Nov 2020 |
To see the full GST registrations and return filing status of Revivaa Biotech Private Limited, buy the company report.
Recent activity
Revivaa Biotech Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Aashish Pruthii was appointed as Director on 16 Apr 2010.
Frequently asked questions
Revivaa Biotech has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Revivaa Biotech was a private limited company based in New Delhi, Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 April 2010 and is registered under CIN U52100DL2010PTC201633. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Revivaa Biotech was incorporated on 16 April 2010. It is registered with the Registrar of Companies, Delhi.
Revivaa Biotech had 2 directors:
- Aashish Pruthii - Director
- Rakesh Kumar Girdhar - Director
The CIN (Corporate Identification Number) of Revivaa Biotech is U52100DL2010PTC201633. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Revivaa Biotech is at M – 134 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001.
The latest financial statements of Revivaa Biotech on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 29 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Revivaa Biotech is 08AAFCR1102C1Z3, registered in Rajasthan.
Revivaa Biotech operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
The peers of Revivaa Biotech by revenue are Orbal Healthcare Private Limited, Utopia Medihealth Private Limited, Ravaxo Pharmaceutical Private Limited, Zoomex Therapeutics Private Limited, Glopec International (India) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Aashish Pruthii was appointed as Director on 16 Apr 2010. Rakesh Kumar Girdhar was appointed as Director on 16 Apr 2010.